Olivier Huillard

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Venues

British journal of cancer

Cancers

Thyroid : official journal of the American Thyroid Association

Therapeutics and clinical risk management

This page only lists publications with an associated author ORCID identifier.

Publications

Alicja Puszkiel, Guillaume Bianconi, Blaise Pasquiers, David Balakirouchenane, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Marie-Claire Bretagne, Joe-Elie Salem, Xavier Declèves, Michel Vidal, Nora Kramkimel, Sarah Guegan, Selim Aractingi, Olivier Huillard, Jérôme Alexandre, Marie Wislez, François Goldwasser, Benoit Blanchet
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients. British journal of cancer 130 (11) (2024)
Alicja Puszkiel, Guillaume Bianconi, Blaise Pasquiers, David Balakirouchenane, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Marie-Claire Bretagne, Joe-Elie Salem, Xavier Declèves, Michel Vidal, Nora Kramkimel, Sarah Guegan, Selim Aractingi, Olivier Huillard, Jérôme Alexandre, Marie Wislez, François Goldwasser, Benoit Blanchet
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients. British journal of cancer 130 (11) (2024)
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, Florent Puisset, David Combarel, Olivier Huillard, Félicien Le Louedec, Fabienne Thomas, Marcus Teixeira, Ronan Flippot, Loic Mourey, Laurence Albiges, Thomas Pudlarz, Charlotte Joly, Christophe Tournigand, Jonathan Chauvin, Alicja Puszkiel, Etienne Chatelut, Xavier Decleves, Michel Vidal, François Goldwasser, Stéphane Oudard, Jacques Medioni, Yann-Alexandre Vano
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care. British journal of cancer 130 (6) (2024)
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, Florent Puisset, David Combarel, Olivier Huillard, Félicien Le Louedec, Fabienne Thomas, Marcus Teixeira, Ronan Flippot, Loic Mourey, Laurence Albiges, Thomas Pudlarz, Charlotte Joly, Christophe Tournigand, Jonathan Chauvin, Alicja Puszkiel, Etienne Chatelut, Xavier Decleves, Michel Vidal, François Goldwasser, Stéphane Oudard, Jacques Medioni, Yann-Alexandre Vano
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care. British journal of cancer (2024)
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, Florent Puisset, David Combarel, Olivier Huillard, Félicien Le Louedec, Fabienne Thomas, Marcus Teixeira, Ronan Flippot, Loic Mourey, Laurence Albiges, Thomas Pudlarz, Charlotte Joly, Christophe Tournigand, Jonathan Chauvin, Alicja Puszkiel, Etienne Chatelut, Xavier Decleves, Michel Vidal, François Goldwasser, Stéphane Oudard, Jacques Medioni, Yann-Alexandre Vano
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care. British journal of cancer 130 (6) (2024)
Alicja Puszkiel, Guillaume Bianconi, Blaise Pasquiers, David Balakirouchenane, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Marie-Claire Bretagne, Joe-Elie Salem, Xavier Declèves, Michel Vidal, Nora Kramkimel, Sarah Guegan, Selim Aractingi, Olivier Huillard, Jérôme Alexandre, Marie Wislez, François Goldwasser, Benoit Blanchet
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients. British journal of cancer (2024)
Alicja Puszkiel, Guillaume Bianconi, Blaise Pasquiers, David Balakirouchenane, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Marie-Claire Bretagne, Joe-Elie Salem, Xavier Declèves, Michel Vidal, Nora Kramkimel, Sarah Guegan, Selim Aractingi, Olivier Huillard, Jérôme Alexandre, Marie Wislez, François Goldwasser, Benoit Blanchet
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients. British journal of cancer 130 (11) (2024)
Benoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, Florent Puisset, David Combarel, Olivier Huillard, Félicien Le Louedec, Fabienne Thomas, Marcus Teixeira, Ronan Flippot, Loic Mourey, Laurence Albiges, Thomas Pudlarz, Charlotte Joly, Christophe Tournigand, Jonathan Chauvin, Alicja Puszkiel, Etienne Chatelut, Xavier Decleves, Michel Vidal, François Goldwasser, Stéphane Oudard, Jacques Medioni, Yann-Alexandre Vano
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care. British journal of cancer 130 (6) (2024)
Louis Schubert, Mohamed Lamine Mariko, Jérôme Clerc, Olivier Huillard, Lionel Groussin
MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data. Cancers 15 (3) (2023)
Louis Schubert, Mohamed Lamine Mariko, Jérôme Clerc, Olivier Huillard, Lionel Groussin
MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data. Cancers 15 (3) (2023)
Laura Nalleli Garrido Castillo, Julien Anract, Nicolas Barry Delongchamps, Olivier Huillard, Fatima BenMohamed, Alessandra Decina, Thierry Lebret, Roger Dachez, Patrizia Paterlini-Bréchot
Polyploid Giant Cancer Cells Are Frequently Found in the Urine of Prostate Cancer Patients. Cancers 15 (13) (2023)
Johanna Noel, Anne Jouinot, Jérôme Alexandre, Guillaume Ulmann, Marie Bretagne, Zahra Castel-Ajgal, Sixtine De Percin, Clémentine Vaquin-Villeminey, Marie-Pierre Revel, Michael Peyromaure, Pascaline Boudou-Rouquette, Jennifer Arrondeau, Ithar Gataa, Jean-Philippe Durand, François Goldwasser, Olivier Huillard
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. Cancers 14 (13) (2022)
Manuela Tiako Meyo, Jeanne Chen, Francois Goldwasser, Laure Hirsch, Olivier Huillard
A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma. Therapeutics and clinical risk management 18 (2022)
Lionel Groussin, Hélène Theodon, Laura Bessiene, Leopoldine Bricaire, Fidéline Bonnet-Serrano, Béatrix Cochand-Priollet, Karen Leroy, Simon Garinet, Eric Pasmant, Jérémie Zerbit, Romain Seban, François Goldwasser, Jérôme Clerc, Anne Segolene Cottereau, Olivier Huillard
Redifferentiating Effect of Larotrectinib in NTRK -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer. Thyroid : official journal of the American Thyroid Association 32 (5) (2022)
Lionel Groussin, Laura Bessiene, Jennifer Arrondeau, Simon Garinet, Béatrix Cochand-Priollet, Audrey Lupo, Jérémie Zerbit, Jérôme Clerc, Olivier Huillard
Letter to the Editor: Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer. Thyroid : official journal of the American Thyroid Association 31 (10) (2021)

Olivier Huillard.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Olivier Huillard